Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition
Authors
Keywords
-
Journal
World Journal of Gastrointestinal Surgery
Volume 14, Issue 6, Pages 528-537
Publisher
Baishideng Publishing Group Inc.
Online
2022-06-27
DOI
10.4240/wjgs.v14.i6.528
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?
- (2021) Shuling Chen et al. RADIOLOGY
- A comparative study of portal vein embolization versus radiation lobectomy with Yttrium-90 micropheres in preparation for liver resection for initially unresectable hepatocellular carcinoma
- (2021) Yuki Bekki et al. SURGERY
- Transarterial chemoembolization plus lenvatinib versus transarterial chemoembolization plus sorafenib as first‐line treatment for hepatocellular carcinoma with portal vein tumor thrombus: A prospective randomized study
- (2021) Xiaoyan Ding et al. CANCER
- Integrated I-125 Seed Implantation Combined with Transarterial Chemoembolization for Treatment of Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus
- (2021) Wansheng Wang et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial
- (2021) Peter R Galle et al. LANCET ONCOLOGY
- Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial
- (2021) Qi-Jiong Li et al. JOURNAL OF CLINICAL ONCOLOGY
- BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
- (2021) Maria Reig et al. JOURNAL OF HEPATOLOGY
- Clinical Significance of the Initial and Best Responses after Chemoembolization in the Treatment of Intermediate-Stage Hepatocellular Carcinoma with Preserved Liver Function
- (2020) Chan Park et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Andrew X Zhu et al. LANCET ONCOLOGY
- Hepatocellular carcinoma with extrahepatic metastasis: Are there still candidates for transarterial chemoembolization as an initial treatment?
- (2019) Jihye Kim et al. PLoS One
- Safety and Feasibility of Helical I-125 Seed Implants Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinomas with Main Portal Vein Tumor Thrombus
- (2019) Wansheng Wang et al. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY
- Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2017 (4th JSH‐HCC Guidelines) a 2019 update
- (2019) Norihiro Kokudo et al. HEPATOLOGY RESEARCH
- Sorafenib with Transarterial Chemoembolization Achieves Improved Survival vs. Sorafenib Alone in Advanced Hepatocellular Carcinoma: A Nationwide Population-Based Cohort Study
- (2019) Victor Kok et al. Cancers
- Lenvatinib as an Initial Treatment in Patients with Intermediate-Stage Hepatocellular Carcinoma Beyond Up-To-Seven Criteria and Child–Pugh A Liver Function: A Proof-Of-Concept Study
- (2019) Masatoshi Kudo et al. Cancers
- Chinese Expert Consensus on Multidisciplinary Diagnosis and Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus (2018 Edition)
- (2019) Shuqun Cheng et al. Liver Cancer
- Add-on sorafenib is beneficial for hepatocellular carcinoma patients with transarterial chemoembolization refractoriness
- (2019) Po-Ting Lin et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Simultaneous transarterial chemoembolization and radiofrequency ablation for large hepatocellular carcinoma
- (2019) Feng Duan et al. World Journal of Gastrointestinal Oncology
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Hepatocellular carcinoma
- (2018) Alejandro Forner et al. LANCET
- Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein
- (2018) Jin Hyoung Kim et al. LIVER INTERNATIONAL
- Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
- (2018) Jean-Luc Raoul et al. CANCER TREATMENT REVIEWS
- AASLD guidelines for the treatment of hepatocellular carcinoma
- (2017) Julie K. Heimbach et al. HEPATOLOGY
- Validation of Clinical Scoring Systems ART and ABCR after Transarterial Chemoembolization of Hepatocellular Carcinoma
- (2017) Roman Kloeckner et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Safety and Efficacy of Irradiation Stent Placement for Malignant Portal Vein Thrombus Combined with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Single-Center Experience
- (2017) Jian Lu et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study
- (2017) Jianbing Wu et al. OncoTargets and Therapy
- Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis
- (2017) Jack P. Silva et al. HPB
- Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic disease
- (2017) Martha M Kirstein et al. United European Gastroenterology Journal
- Iodine-125 implantation plus transarterial chemoembolization for the treatment of hepatocellular carcinoma of 3–5cm: A propensity score matching study
- (2016) Minpeng Li et al. DIGESTIVE AND LIVER DISEASE
- Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
- (2015) Xavier Adhoute et al. JOURNAL OF HEPATOLOGY
- Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
- (2015) Joong-Won Park et al. LIVER INTERNATIONAL
- Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization
- (2015) Atsushi Hiraoka et al. ONCOLOGY
- Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma
- (2015) Tadaaki Arizumi et al. Liver Cancer
- Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
- (2014) Masatoshi Kudo et al. ONCOLOGY
- Efficacy of Sorafenib in Intermediate-Stage Hepatocellular Carcinoma Patients Refractory to Transarterial Chemoembolization
- (2014) Sadahisa Ogasawara et al. ONCOLOGY
- How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
- (2014) Jean-Luc Raoul et al. Liver Cancer
- Transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a meta-analysis
- (2013) Tong-Chun Xue et al. BMC GASTROENTEROLOGY
- Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
- (2013) Takahide Nakazawa et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
- (2013) Wolfgang Sieghart et al. HEPATOLOGY
- Assessment of treatment outcomes based on tumor marker trends in patients with recurrent hepatocellular carcinoma undergoing trans-catheter arterial chemo-embolization
- (2013) Takuma Arai et al. International Journal of Clinical Oncology
- Sorafenib Alone versus Sorafenib Combined with Transarterial Chemoembolization for Advanced-Stage Hepatocellular Carcinoma: Results of Propensity Score Analyses
- (2013) Gwang Hyeon Choi et al. RADIOLOGY
- Clinical Significance of AFP and PIVKA-II Responses for Monitoring Treatment Outcomes and Predicting Prognosis in Patients with Hepatocellular Carcinoma
- (2013) Hana Park et al. Biomed Research International
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia–Pacific trial
- (2012) Ann-Lii Cheng et al. EUROPEAN JOURNAL OF CANCER
- Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
- (2012) Jordi Bruix et al. JOURNAL OF HEPATOLOGY
- Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)
- (2012) Joong-Won Park et al. LIVER INTERNATIONAL
- Lack of Response after Initial Chemoembolization for Hepatocellular Carcinoma: Does It Predict Failure of Subsequent Treatment?
- (2012) Christos Georgiades et al. RADIOLOGY
- Management of Hepatocellular Carcinoma in Japan: Consensus-Based Clinical Practice Guidelines Proposed by the Japan Society of Hepatology (JSH) 2010 Updated Version
- (2011) Masatoshi Kudo et al. DIGESTIVE DISEASES
- Portal blood supply to locally progressed hepatocellular carcinoma after transcatheter arterial chemoembolization: Observation on CT during arterial portography
- (2011) Shiro Miyayama et al. HEPATOLOGY RESEARCH
- Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
- (2011) Hwi Young Kim et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Mixed phenotype hepatocellular carcinoma after transarterial chemoembolization and liver transplantation
- (2011) Chikako Zen et al. LIVER TRANSPLANTATION
- Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
- (2010) J.-L. Raoul et al. CANCER TREATMENT REVIEWS
- Response Evaluation Criteria in Cancer of the Liver (RECICL) proposed by the Liver Cancer Study Group of Japan (2009 Revised Version)
- (2010) Masatoshi Kudo et al. HEPATOLOGY RESEARCH
- Multistep human hepatocarcinogenesis: correlation of imaging with pathology
- (2009) Masatoshi Kudo JOURNAL OF GASTROENTEROLOGY
- Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia
- (2008) HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More